Jul 10, 2023 | Advocacy, Featured, Stories of D Life, Technology Updates
Mark Your Calendars: TCOYD and The diaTribe Foundation invite you to join us for the 17th Annual (4th Virtual!) Diabetes Forum, 26 July 2023, 4:00pm PT/ 1pm HT/ 5pm MT/ 6pm CT/ 7pm ET) Every year, this unique event invites a panel of diabetes experts...
Jul 5, 2023 | Advocacy, Featured, Research News, Technology Updates
FDA approves novel pancreatic islet cell therapy for adults with type 1 diabetes by Jill Rollet for Healio.com/endocrinology, 29 June 2023. The FDA approved an allogenic pancreatic islet cellular therapy for adults with type 1 diabetes who struggled to achieve their...
Jun 26, 2023 | Advocacy, Exercise, Featured, Research News, Technology Updates, Videos
Is plant-based, oral insulin within reach for diabetes treatment? by Paul Ian Cross for MedicalNewsToday.com, 21 June 2023. New research, published in the journal Biomaterials, suggests that a plant-based oral delivery method of proinsulin could...
Jun 19, 2023 | Advocacy, Eating, Featured, Research News, Technology Updates
Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes, an upcoming presentation by Dana M. Lewis, developer of OpenAPS, to the American Diabetes Association 83rd Scientific Sessions, 23 June 2023. What is your presentation about? This...
Jun 12, 2023 | Advocacy, Featured, Research News, Stories of D Life, Technology Updates, Videos
Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M by Elise Reuter for MedTechDive.com, 5 June 2023. Novo Nordisk wants to innovate faster and develop new connected devices, and expects that Biocorp would complement its internal efforts, said...
May 30, 2023 | Featured, Podcasts, Research News, Stories of D Life, Technology Updates
Medtronic to acquire South Korean wearable insulin patch maker EOFlow by Ravikash for SeekingAlpha.com, 25 May 2023. Medtronic is acquiring South Korea-based wearable insulin patch maker EOFlow in a deal worth KRW 971B ($738M). The acquisition will...